Rossari Biotech

₹711.6 -1.5 | 0.2%

WEBSITE BSE:543213 NSE : ROSSARI 10 May, 16:01

Market Cap ₹3931 Cr.

Stock P/E 30.1

P/B 3.8

Current Price ₹711.6

Book Value ₹ 189.7

Face Value 2

52W High ₹903.5

Dividend Yield 0.07%

52W Low ₹ 665.3

Edit Ratio

Rossari Biotech Research see more...

Overview Inc. Year: 2003Industry: Chemicals

Rossari Biotech Ltd manufactures and sells speciality chemical substances in India and the world over. It offers home, private care and overall performance chemical products, including soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; and water remedy solutions. The business enterprise additionally provides textile speciality chemical substances, inclusive of cotton, polyester, acrylic, wool, silk, nylon, denim, and sustainable solutions; and pet grooming products, which encompass natural pet shampoos, powders, deodorants, sprays, creams, and ground washing drinks beneath the Lozalo, Hunger Fills, and Sniffy emblem names. In addition, it provides poultry nutrients merchandise comprising vitamin-mineral formulations, toxin binders, individual and cocktail enzymes, liquid nutraceuticals, and supplements or natural preparations. The enterprise previously referred to as Rossari Labtech and changed its call to Rossari Biotech Ltd in December 2003. Rossari Biotech Ltd founded in 2003 and is based in Mumbai, India.

Rossari Biotech Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Rossari Biotech Quarterly Results

#(Fig in Cr.)	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Net Sales	428	439	435	425	389	406	411	483	464	473
Other Income	5	2	1	1	1	3	2	1	4	0
Total Income	434	441	435	426	390	409	413	485	467	473
Total Expenditure	381	387	377	369	335	352	353	420	400	409
Operating Profit	53	54	58	57	55	57	60	65	67	64
Interest	3	5	5	8	5	4	6	5	4	3
Depreciation	18	17	15	16	16	16	14	15	15	16
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	32	33	38	34	35	37	40	45	48	45
Provision for Tax	9	10	10	10	9	8	10	12	13	11
Profit After Tax	22	23	28	24	26	29	29	33	34	34
Adjustments	0	1	1	0	0	0	-0	0	0	0
Profit After Adjustments	23	24	29	24	26	29	29	33	34	34
Adjusted Earnings Per Share	4.1	4.4	5.2	4.3	4.7	5.3	5.3	6	6.2	6.2

Rossari Biotech Profit & Loss

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	155	171	179	233	292	516	600	709	1483	1656	1831
Other Income	0	0	0	1	1	1	4	9	19	14	7
Total Income	155	171	179	234	293	517	604	719	1502	1670	1838
Total Expenditure	140	156	166	209	247	439	495	586	1307	1441	1582
Operating Profit	15	15	13	25	46	78	108	132	195	229	256
Interest	5	5	4	2	1	3	4	3	13	22	18
Depreciation	5	5	5	4	5	12	17	23	48	63	60
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	4	5	5	19	40	63	88	107	136	144	178
Provision for Tax	1	1	1	3	11	18	23	27	39	37	46
Profit After Tax	4	4	3	16	29	46	65	80	98	107	130
Adjustments	0	0	0	0	0	0	0	0	-0	0	0
Profit After Adjustments	4	4	3	16	29	46	65	80	98	107	130
Adjusted Earnings Per Share	0.8	0.8	0.7	3.3	6	9.4	12.9	15.4	17.7	19.4	23.7

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	12%	40%	41%	0%
Operating Profit CAGR	17%	28%	38%	0%
PAT CAGR	9%	18%	30%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	3%	-17%	NA%	NA%
ROE Average	13%	17%	25%	21%
ROCE Average	18%	24%	33%	26%

Rossari Biotech Balance Sheet

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	48	47	50	65	94	124	287	409	805	915
Minority's Interest	0	0	0	0	0	0	0	0	0	0
Borrowings	7	9	7	2	1	1	34	0	0	35
Other Non-Current Liabilities	0	0	-0	-0	2	36	35	59	251	148
Total Current Liabilities	70	58	52	57	68	122	169	177	360	474
Total Liabilities	125	114	109	124	166	283	525	645	1417	1572
Fixed Assets	42	38	38	38	45	74	94	181	607	584
Other Non-Current Assets	8	8	8	9	15	49	85	82	135	140
Total Current Assets	76	69	63	77	106	160	346	381	675	848
Total Assets	125	114	109	124	166	283	525	645	1417	1572

Rossari Biotech Cash Flow

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	1	1	1	3	2	1	6	29	15	37
Cash Flow from Operating Activities	15	8	26	7	24	71	57	48	29	152
Cash Flow from Investing Activities	-4	-2	-5	-6	-20	-36	-190	-37	-299	-181
Cash Flow from Financing Activities	-11	-6	-19	-2	-5	-29	157	-25	292	61
Net Cash Inflow / Outflow	0	0	2	-0	-2	6	23	-14	22	32
Closing Cash & Cash Equivalent	1	1	3	2	1	6	29	15	37	70

Rossari Biotech Ratios

#	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	0.79	0.77	0.7	3.25	5.99	9.44	12.86	15.45	17.74	19.45
CEPS(Rs)	1.84	1.82	1.63	4.13	7.06	11.96	16.18	19.81	26.47	30.86
DPS(Rs)	0.1	0.1	0	0	4	1	0.5	0.5	0.5	0.5
Book NAV/Share(Rs)	9.14	9.69	10.33	13.5	19.5	25.58	56.39	78.31	145.65	165.29
Core EBITDA Margin(%)	9.46	8.52	7.01	10.43	14.95	15.01	17.37	17.21	11.84	12.85
EBIT Margin(%)	6.38	5.72	4.69	9.03	13.69	12.83	15.15	15.36	10	9.98
Pre Tax Margin(%)	2.88	2.77	2.72	8.11	13.24	12.27	14.56	14.94	9.15	8.64
PAT Margin (%)	2.45	2.18	1.89	6.74	9.71	8.84	10.82	11.19	6.56	6.43
Cash Profit Margin (%)	5.74	5.15	4.42	8.57	11.44	11.2	13.61	14.38	9.78	10.2
ROA(%)	3.03	3.11	3.04	13.49	20	20.38	16.17	13.69	9.48	7.18
ROE(%)	8.6	8.18	6.99	27.27	36.33	41.88	31.83	23.11	16.17	12.52
ROCE(%)	10.69	10.7	10.3	26.4	40.37	54.4	37.93	28.81	24.37	18.48
Receivable days	66.45	61.77	61.97	61.34	65.53	51.48	54.48	60.78	55	72
Inventory Days	98.62	78.22	57.73	38.07	35.88	31.8	34.21	39.17	34.95	41.37
Payable days	93.52	68.05	65.27	66.35	67.16	78.74	99.66	90.07	52.27	57.86
PER(x)	0	0	0	0	0	0	0	67.17	51.49	30.61
Price/Book(x)	0	0	0	0	0	0	0	13.25	6.27	3.6
Dividend Yield(%)	0	0	0	0	0	0	0	0.05	0.05	0.08
EV/Net Sales(x)	0.31	0.27	0.13	0.1	0.08	0.01	-0.08	7.47	3.36	1.95
EV/Core EBITDA(x)	3.18	3.15	1.86	0.95	0.53	0.04	-0.46	40.08	25.51	14.15
Net Sales Growth(%)	0	10.37	4.44	30.64	25.02	76.91	16.25	18.21	109.06	11.66
EBIT Growth(%)	0	-1.01	-14.44	151.42	94.16	62.02	37.92	20.17	35.6	11.82
PAT Growth(%)	0	-2.03	-9.17	364.63	84.44	57.46	42.84	22.67	22.05	9.79
EPS Growth(%)	0	-2.03	-9.17	364.63	84.44	57.46	36.21	20.15	14.85	9.61
Debt/Equity(x)	1	0.93	0.45	0.34	0.22	0.04	0.23	0	0.01	0.08
Current Ratio(x)	1.09	1.17	1.21	1.35	1.56	1.31	2.05	2.16	1.87	1.79
Quick Ratio(x)	0.49	0.63	0.73	0.94	1.04	0.86	1.71	1.62	1.35	1.39
Interest Cover(x)	1.82	1.94	2.38	9.85	30.15	23.03	25.7	36.71	11.77	7.46
Total Debt/Mcap(x)	0	0	0	0	0	0	0	0	0	0.02

Rossari Biotech Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	68.56	68.56	68.56	68.46	68.44	68.43	68.43	68.35	68.33	68.32
FII	9.13	9.03	8.51	8.84	8.63	7.46	6.12	5.75	4.14	4.03
DII	12.77	12.29	13.03	14.15	14.08	15.09	17.71	17.68	18.06	17.75
Public	9.54	10.12	9.91	8.54	8.85	9.01	7.73	8.23	9.46	9.9
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	3.77	3.77	3.77	3.77	3.77	3.77	3.77	3.77	3.77	3.77
FII	0.5	0.5	0.47	0.49	0.48	0.41	0.34	0.32	0.23	0.22
DII	0.7	0.68	0.72	0.78	0.78	0.83	0.98	0.98	1	0.98
Public	0.53	0.56	0.55	0.47	0.49	0.5	0.43	0.45	0.52	0.55
Others	0	0	0	0	0	0	0	0	0	0
Total	5.51	5.51	5.51	5.51	5.52	5.52	5.52	5.52	5.52	5.52

Pros

Company has delivered good profit growth of 29% CAGR over last 5 years
Company is almost debt free.

Cons

Debtor days have increased from 52.27 to 57.86days.
Stock is trading at 3.8 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.